Search results
Rutherrin(R) Increases Efficacy of Chemotherapy
The Joplin Globe· 45 minutes ago("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated ...
Tacalyx extends seed funding round to raise over €14m
Pharmaceutical Technology via Yahoo Finance· 3 hours ago“With...fusion platform in a deal worth up to $1.2bn. "Tacalyx extends seed funding round to raise...
UNF researchers secure patent for groundbreaking cancer-fighting compound that can ‘turn off’ cancer
WJAX via Yahoo News· 2 hours agoThree University of North Florida researchers have made a breakthrough in the fight against cancer,...
Is Eli Lilly the Best Pharmaceutical Stock for You?
Motley Fool via Yahoo Finance· 6 hours agoEli Lilly (NYSE: LLY) stock has soared 90% over the past year, a huge gain for a pharmaceutical company. These stocks generally are known for steady...
Johnson & Johnson agrees to pay $700M to settle talcum lawsuit with dozens of states
United Press International via Yahoo News· 6 hours agoU.S. pharmaceutical giant Johnson & Johnson has agree to pay $700 million to settle lawsuits filed...
Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug...
San Mateo Daily Journal· 3 hours agoInvestor webcast on or before July 23 will include updates on Jaguar's cancer supportive care...
Insider Sale: CEO Brian Goff Sells Shares of Agios Pharmaceuticals Inc (AGIO)
GuruFocus.com via Yahoo Finance· 5 days agoFollowing this transaction, the insider now owns 67,192 shares of the company. Agios Pharmaceuticals...
Rectal cancer disappears in patients treated with new drug in promising clinical trial
Euronews via Yahoo News· 5 hours agoA study showed a 100 per cent positive response rate in 42 patients with a specific type of rectal ...
Salarius announces reverse stock split to meet Nasdaq requirements By Investing.com
Investing.com· 2 hours agoSalarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a biopharmaceutical company focused on developing ...
Processa reports positive Phase 1b trial results for cancer drug By Investing.com
Investing.com· 1 day agoProcessa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company, has announced...
